Simon Douglas

Simon Douglas is an experienced leader in the biotechnology and diagnostic sectors, currently serving as Non Executive Chairman at Abselion and Fusion Antibodies plc, alongside roles as Chief Executive at C Major Medical and Non Executive Chairman at Cambridge Nutritional Sciences plc. With a background that includes pivotal positions such as Chief Executive at Biofortuna and Executive Chairman at Lab 901, Simon has a rich history in developing innovative laboratory instruments and healthcare solutions. Educational credentials include a PhD in Antibody Imaging of Tumours and a BSc in Chemistry, both from the University of Southampton.